Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report

Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Soc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Catarina, Bergmann, Michael, Briukhovetska, Daria, Nuessler, Volkmar, Sznol, Mario, von Bergwelt-Baildon, Michael, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057436/
https://www.ncbi.nlm.nih.gov/pubmed/32114499
http://dx.doi.org/10.1136/jitc-2019-000268
_version_ 1783503658145546240
author Pinto, Catarina
Bergmann, Michael
Briukhovetska, Daria
Nuessler, Volkmar
Sznol, Mario
von Bergwelt-Baildon, Michael
Kobold, Sebastian
author_facet Pinto, Catarina
Bergmann, Michael
Briukhovetska, Daria
Nuessler, Volkmar
Sznol, Mario
von Bergwelt-Baildon, Michael
Kobold, Sebastian
author_sort Pinto, Catarina
collection PubMed
description Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Society of the Immunotherapy of Cancer to bring the European researchers together. In its sixth edition, the ITOC conference has recently been held in Vienna, Austria.
format Online
Article
Text
id pubmed-7057436
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70574362020-03-05 Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report Pinto, Catarina Bergmann, Michael Briukhovetska, Daria Nuessler, Volkmar Sznol, Mario von Bergwelt-Baildon, Michael Kobold, Sebastian J Immunother Cancer Meeting Report Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Society of the Immunotherapy of Cancer to bring the European researchers together. In its sixth edition, the ITOC conference has recently been held in Vienna, Austria. BMJ Publishing Group 2020-02-28 /pmc/articles/PMC7057436/ /pubmed/32114499 http://dx.doi.org/10.1136/jitc-2019-000268 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Meeting Report
Pinto, Catarina
Bergmann, Michael
Briukhovetska, Daria
Nuessler, Volkmar
Sznol, Mario
von Bergwelt-Baildon, Michael
Kobold, Sebastian
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title_full Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title_fullStr Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title_full_unstemmed Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title_short Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report
title_sort sixth immunotherapy of cancer conference (itoc): advances and perspectives—a meeting report
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057436/
https://www.ncbi.nlm.nih.gov/pubmed/32114499
http://dx.doi.org/10.1136/jitc-2019-000268
work_keys_str_mv AT pintocatarina sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT bergmannmichael sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT briukhovetskadaria sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT nuesslervolkmar sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT sznolmario sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT vonbergweltbaildonmichael sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport
AT koboldsebastian sixthimmunotherapyofcancerconferenceitocadvancesandperspectivesameetingreport

Ejemplares similares